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Cost consideration has special relevance in psychiatric practice, where the drug treatment has to be continued for long 
duration. On evaluating, the cost of different brand names, of the same generic drug using CI MS and MIMS (India, 
1991), it was found that Cost Range and Cost Ratio varies considerably. The Cost Ratio is more than 3 for Tab. 
Thioridazone 100 mg and Cap. Daxepin 75 mg. Since, the superiority of any costlier brand over the others has never 
been reported, and keeping in view the financial aspect of prescribing the cheapest of the brand available should be 
prescribed, whenever possible. ___ 
X he use of drugs with well-demonstrated efficacy 
in psychiatric disorder has become widespread since 
mid-1950s. Today, about 10 to 20% of prescriptions 
written in the United States are of medications in-
tended to affect mental process, namely, to sedate, 
stimulate or otherwise change mood, thinking or be-
haviour (Baldessarini, 1990). In India, also, the situa-
tion is equally bad and psychiatric medications are 
prescribed substantially. 
Although, the drugs in psychiatric practice have 
a revolutionary, beneficial impact, the cost considera-
tion is of special relevance in this field because the 
majority of the drugs have to be taken for appreciably 
long duration. The patient's illness, as such, by prevent-
ing their gainful employments creates an additional 
burden on the patients. Over and above this, the 
physician's lack of knowledge regarding the cost of 
drugs, affect the patient's finances severely (Kaine and 
O'Connell, 1972; Lowyer at., 1972). So, while treating a 
patient, it is our moral duty to consider the economic 
feature of prescribing as well. 
This problem can be tackled to some extent by 
prescribing in generic names, as some studies docu-
ment that generic drug cost less than the branded ones 
(Horvitz et al., 1975). Whereas other studies say that 
there is no difference in the cost of generic and branded 
drugs (Ritch et al., 1978; Kass and Gordon, 1981). 
At the same time, as there are different brands,. 
of the same generic drug, it might be expected, that 
their cost also varies but it has not been investigated so 
far. The present study was planned to investigate the 
cost difference in different brands of the same generic 
drug, so that whenever possible a cheaper brand can be 
prescribed, since the inferiority of any cheaper brand 
over the other, of the same generic drug, has not been 
reported. 
MATERIAL AND METHOD 
J. he cost in Rupees among different brand names 
of the same generic drugs was evaluated using CIMS 
(30: May-August, 1991, India) and MIMS (11: July, 
1991, India). The cost of 10 tablets, 10 capsule or 1 
injection of all the brands of various drugs e.g. bar-
biturates (phenobarbitone), benzodiazepines 
(diazepam, nitrazepam, lorazepam, alprazolam and 
chlordiazepoxide), butyrophenones (haloperidol), 
phenothiazines (chlorpromazine, thioridazine, 
fluphenazine, trifluperazine), diphenyl butyl-
piperidines (pimozide, penfluridol), atypical agents 
(buspirone), tricyclic antidepressants (amitriptyline, 
nortriptyline, imipramine, doxepin), atypical an-
tidepressants (trazodone and fluoxetine), lithium and 
others (mianserin) was evaluated. 
To get some idea of the difference in the cost 
between the costliest and cheapest brand, the cost 
range, which is range in the cost from cheapest to 
costliest brand of the same generic drug was calculated. 
The cost ratio, the ratio of the cost of the costliest to 
cheapest brand of the same generic drug was also cal-
culated. This tells, how many times the costliest brand 
costs more than the cheapest one in each generic drug. 
RESULTS 
J. he cost range varies widely in, the different drugs 
(Table 1,2 and 3). The cost ratio is highest for 
thioridazones, doxepin, alprazolam, haloperidol, 
trazodone, chlorpromazine, diazepam, imipramine, 
lithium and amitriptyline, whereas it is low for 
phenobarbitone, nortriptyline, mianserin, chlor-
diazepoxide, lorazepam and pimozide (Table 1,23). 
Table 1. Cost Range, Cost Ratio, Number of brands 
available and strength of each prepation of bar-
biturates and benzodiazepines. 
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Drugs 
L Barbiturates: 
Tab Pheenobarbitone 
IL Benzodiaxepines: 
a.)Tab Diazepam 
Inj Diazepam (2ml) 
b.)Tab Nitrazepam 
c.) Tab Lorazepam 
d)Tab Alprazolam 
e.)Tab Chlordiazeparide 
Strength 
30 mg 
2mg 
5mg 
lOmg 
5mg/ml 
Smg 
lOmg 
lmg 
2mg 
035mg 
030mg 
lmg 
lOmg 
No. of 
brands 
2 
4 
9 
5 
5 
5 
5 
3 
3 
7 
7 
7 
2 
Cost Range (in Rs.) 
1.19-1.21 
136-230 
1.87-339 
2.73-4.92-
1.47-2.14 
33-53 
5-73 
2*0-3.06 
3.90-4.08 
230-6.0 
3.90-11.0 
735-14.0 
339-336 
Cost Ratio 
1.02 
1.41 
1.76 
L80 
1.46 
13 
1.09 
1.05 
2.73 
2J82 
1.93 
1.05 
Table 2. Cost Range, Cost Ratio, number of brands and strength of each prepatlon ofbutyropbenones, 
pbenothiazines, diphenyl btrtylplperidines and atypical agents. 
Drugs 
Butyrophenones 
Tab Haloperidol 
Inj Haloperidol (1ml) 
Phenothiazines 
Tab Chlorpromazines 
Inj Chlopromazine 
Tab Thioridazine 
Inj Fluphenazines (1ml) 
Tab Trifluperazine 
Diphenyt butyipiperidines 
Tab Pimozide 
Tab Penfluridol 
Atypical Agents 
Tab Burpironc 
Tab Propranolol 
Strength 
035mg 
13mg 
5.0mg 
lOmg 
20mg 
5mglml 
25mg 
50mg 
lOOmg 
200mg 
2mg/ml 
lOmg 
25mg 
50mg 
lOOmg 
25mg/ml 
5mg 
2mg 
4mg 
20mg 
5mg 
lOmg 
No. of brands 
3 
6 
7 
5 
3 
3 
3 
3 
3 
2 
3 
4 
5 
4 
5 
2 
2 
4 
5 
2 
3 
3 
Cost Range (inRs.) 
2.25 - 3.02 
3.88-938 
830 - 21.47 
15.0-27.97 
28.0 - 30.00 
33-4.00 
234-4.64 
3.70-6.63 
530 - 9.90 
103 -14.00 
330 - 3.73 
330-5.08 
7.40-11.20 
13.80 -16.00 
1230 - 44.72 
12.0-15.00 
330 - 3.90 
9.60 -1030 
15.0 -16.00 
48.12-65.00 
5.40-6.64 
9.60 -1030 
Cost Ratio 
134 
2,47 
2.62 
1.86 
L07 
1.14 
2.07 
1.79 
1.64 
133 
1.06 
1.45 
131 
1.16 
338 
135 
1.11 
1.09 
1.07 
137 
133 
1.09 20  AVTARLAL, etal 
Table 3. Cost Range, Cost Ratio, number of brands and strength of each preparation of tricyclic aatideprca-
sants, atypical antidepressants, lithium and others. 
Drugs 
Tricyclic Antidepressants: 
Tab Nortriptyline 
Tab Imipraminc 
Cap Doxepin 
Atypical Antidepressants: 
Tab Trazodone 
Tab Fluoxetine 
Tab Lithium Carbonate 
Other Agents: 
Tab Mianserin 
Strength 
lOmg 
25mg 
75mg 
25mg 
25mg 
75mg 
lOmg 
25mg 
75mg 
25mg 
50mg 
lOOmg 
20mg 
150 
300 
lOmg 
20mg 
No. of brands 
5 
7 
5 
2 
5 
5 
4 
4 
3 
7 
8 
6 
3 
2 
4 
3 
2 
Cost Range 
2.00 - 3.15 
4.20-5.65 
950 -1335 
4.20-4.40 
3.80-6.03 
950-1333 
450-8.24 
8.09 -1954 
10.11 - 3154 
8.00-11.00 
14.00-21.00 
16.00-38.00 
26.00-39.00 
330-5.22 
4.80-5.40 
1425-15.00 
2750-29.00 
Cost Ratio 
157 
135 
1.41 
1.05 
159 
1.40 
1.83 
Z42 
3.12 
137 
150 
238 
150 
158 
1.12 
LOS 
1.05 
DISCUSSION 
X he results indicate that there exists a consider-
able difference in the Cost Range and Cost Ratio 
among different generic drug. Wc have only calculated 
the Cost Range for 10 tablets, 10 capsule or 1 injection 
for each drug. However, in psychiatric practice the 
treatment has to be given for long duration and in some 
cases for many years. So in that case, the Cost Range 
would be quite wide and the difference in the cost of 
treatment would be appreciably high. The Cost Ratio 
is 3.58 for Tab thioridazine 100 mg indicating, that the 
costliest brand is 3.58 time costlier than the cheapest 
one. Since, the superiority or inferiority of any costliest 
brand over the inferior one, of the same generic drug, 
has never been scientifically established, a conscien-
tious prescribe r should always choose the cheapest 
brand, available while prescribing. 
At the same time, as the physicians have general-
ly suboptimal awareness of the drug cost (Kaine and 
O'Connel, 1972, Lowy el ai, 1972), the situation can be 
improved, if drug price is given greater emphasis during 
medical training programme (Brody and Stokes, 1970). 
The medication cost should be another property of the 
drug and the average coat per specified dose shculd be 
listed in medical literature, drug advertisement The 
drug cost mentioned in our study is of ethical phar-
maceutical preparations, appearing in CIMS and 
MIMS (India). The cheapest brand among the ethical 
preparations should be preferred while prescribing, 
whereas, the cheapest brand from unethical and un-
standard preparation should be discouraged. 
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